Chargement en cours...
Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
BACKGROUND: In a randomized phase III trial of sunitinib vs interferon-alfa (IFN-α) in metastatic renal cell carcinoma (mRCC), better baseline quality of life (QoL) was predictive of longer survival. Using this dataset, we have developed a novel prognostic tool that establishes a relationship betwee...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3322947/ https://ncbi.nlm.nih.gov/pubmed/22240794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.589 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|